The expanding demand for specific immunological study and therapeutic development has spurred significant advances in recombinant signal molecule production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using multiple expression systems, including prokaryotic hosts, mammalian cell populations, a